← Product Code [MHX](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/MHX) · K970182 # DINAMAP COMPACT MONITOR (K970182) _Johnson & Johnson Medical, Inc. · MHX · Aug 18, 1997 · Cardiovascular · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/MHX/K970182 ## Device Facts - **Applicant:** Johnson & Johnson Medical, Inc. - **Product Code:** [MHX](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/MHX.md) - **Decision Date:** Aug 18, 1997 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 870.1025 - **Device Class:** Class 2 - **Review Panel:** Cardiovascular - **Attributes:** Pediatric ## Indications for Use The DINAMAP Compact Monitor is intended to monitor a single adult, pediatric or neonatal patient’s vital signs at the bedside. Vital signs parameters include noninvasive blood pressure (systolic, diastolic and mean arterial pressure), pulse rate, temperature and/or oxygen saturation (pulse oximetry). The portable device is designed for use in numerous clinical settings, primarily in various hospital departments such as emergency, radiology, recovery, medical/surgical, labor & delivery, endoscopy, cardiac step-down, etc. and can also be used during many specialized procedures in satellite areas, or in ambulatory surgery centers, physicians’ offices or alternate care settings. ## Device Story Portable bedside monitor for adult, pediatric, neonatal patients; used in hospitals, surgery centers, physician offices. Inputs: oscillometric NIBP/heart rate; red/infrared spectroscopy (Nellcor pulse oximetry); thermistor-based temperature. Device processes signals to display vital signs; optional printer/recorder; connectivity to central stations/host systems. Operated by healthcare professionals. Benefits: continuous bedside monitoring for clinical decision-making. ## Clinical Evidence Clinical studies conducted for predictive thermometry accuracy and NIBP accuracy across adult, pediatric, and neonatal populations. Bench testing performed for pulse oximetry, environmental, and electromagnetic compatibility. No specific numerical results provided in summary. ## Technological Characteristics Software-driven electronic monitor. NIBP: oscillometry. Pulse Oximetry: red/infrared spectroscopy (Nellcor). Temperature: thermistor with predictive algorithm. Portable, battery/AC powered. Connectivity: central station/host system interface. No new technological characteristics compared to predicates. ## Regulatory Identification The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs. ## Special Controls *Classification.* Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document. ## Predicate Devices - DINAMAP PLUS Monitor Model 9700 ([K943709](/device/K943709.md), [K912188](/device/K912188.md)) - DINAMAP XL Monitor ([K942700](/device/K942700.md)) - Nellcor® Model N-180 Pulse Oximeter ([K913695](/device/K913695.md)) ## Reference Devices - Sherwood Medical Inc. FirstTemp™ Genius™ Infrared Tympanic Thermometry Unit ([K920713](/device/K920713.md)) - OBSERVER® Central Station ([K933404](/device/K933404.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0} Johnson & Johnson MEDICAL INC. K970182 AUG 18 1997 # 510(k) Summary | Date | January 16, 1997 | | --- | --- | | Contact | Annette M. Hillring Director, Regulatory Affairs Johnson & Johnson Medical, Inc. 4110 George Road Tampa, Florida 33634 Telephone: (813) 887-2256 Telefax: (813) 887-2263 | | Device Name | DINAMAP* Compact Monitor | | Common Names | Physiological or Vital Signs Monitor, Patient Monitor Includes the following monitoring parameters: • Noninvasive Blood Pressure & Heart Rate • Pulse Oximetry & Heart Rate • Predictive Temperature An optional recorder is also available. | | Classification | The classification names, 21 Code of Federal Regulations (CFR) Part and Paragraph numbers, and classification of the DINAMAP Compact Monitor and its monitoring parameters follow. The tier categorization based on the list (January 27, 1994) distributed by the Office of Device Evaluation is also included. | Continued on next page 4110 GEORGE ROAD, TAMPA, FL 33634 • 813-887-2000 {1} 510(k) Summary, Continued ## Classification (continued) | Classification Name | 21 CFR § & Class | Tier | | --- | --- | --- | | System, Measurement, Blood Pressure, Noninvasive | 870.1130 II | 2 | | Computer, Blood Pressure | 870.1110 II | 2 | | Alarm, Blood Pressure | 870.1100 II | 2 | | Oximeter | 870.2700 II | 2 | | Oximeter, Ear | 870.2710 II | 2 | | Thermometer, Clinical Electronic | 880.2910 II | 2 | | Recorder, Paper Chart | 870.2810 II | 1 | | Display, Cathode-Ray Tube, Medical | 870.2450 II | 1 | ## Predicate Devices The following table summarizes the predicate devices for the Compact Monitor and its monitoring parameters and 510(k) numbers: | Compact | Predicate Device & Model | 510(k) Number(s) | | --- | --- | --- | | System | DINAMAP PLUS Monitor Model 9700 | K943709 K912188 | | System | DINAMAP XL Monitor | K942700 | | Temperature | DINAMAP XL Monitor | K942700 | | NIBP | DINAMAP PLUS Monitor Model 9700 | K943709 K912188 K942700 | | Oximetry | Nellcor® Model N-180 Pulse Oximeter DINAMAP PLUS Monitor Model 9700 | K913695 K943709 K912188 | Continued on next page {2} 510(k) Summary, Continued ## Device Description The DINAMAP Compact Monitor is a prescription device intended for use only by health care professionals. Three configurations of the monitor with the following vital signs parameters will be available: - Noninvasive Blood Pressure and Heart Rate, - Noninvasive Blood Pressure and Heart Rate, and Predictive Oral/Rectal Thermometry - Noninvasive Blood Pressure and Heart Rate, Predictive Thermometry, and Nellcor® Pulse Oximetry and Heart Rate In addition, the currently-marketed Sherwood Medical Inc. FirstTemp™ Genius™ Infrared Tympanic Thermometry Unit (K920713) may be physically attached to the side of (but not electrically integrated with) the DINAMAP Compact Monitor. The device is designed for monitoring adult, pediatric and neonatal patients in hospital, outpatient surgery center, physician office and/or alternate healthcare settings. It is portable and capable of operation from an external power source or an internal lead-acid rechargeable battery. An optional printer is also available. The Compact Monitor provides connection for the currently marketed Johnson & Johnson Medical, Inc. (JJMI, formerly Critikon, Inc.) OBSERVER® Central Station (K933404), other monitoring devices, a remote display, data collection system, remote alarm and/or host information system. ## Indications The DINAMAP Compact Monitor is intended to monitor a single patient’s vital signs at the bedside. The patient populations include adult, pediatric and neonatal. Continued on next page iv - 3 {3} iv - 4 # 510(k) Summary, Continued ## Technological Characteristics The DINAMAP Compact Monitor and its monitoring parameters have the same technological characteristics as the predicate devices. There are no new technological characteristics. The Compact Monitor and the predicate devices are all software-driven electronic devices. The Compact monitoring parameters and predicate devices monitoring parameters utilize the following technologies: - Noninvasive Blood Pressure & Heart Rate: Oscillometry - Pulse Oximetry & Heart Rate: Nellcor®, Inc., red & infrared spectroscopy - Thermometry: Thermistor with predictive algorithm ## Nonclinical Tests Several bench studies were conducted which demonstrate safety and effectiveness of the Compact Monitor and monitoring parameters: - Pulse Oximetry - Environmental - Electromagnetic Compatibility ## Clinical Tests Several clinical studies were conducted which demonstrate safety and effectiveness of the Compact Monitor and monitoring parameters: - Predictive Thermometry Accuracy - Adult Noninvasive Blood Pressure Accuracy - Pediatric Noninvasive Blood Pressure Accuracy - Neonatal Noninvasive Blood Pressure Accuracy ## Conclusions In accordance with the Federal Food, Drug and Cosmetic Act and 21 CFR Part 807, and based on the information provided in this premarket notification, Johnson & Johnson Medical concludes that the new device, the DINAMAP Compact Monitor is safe, effective and substantially equivalent to the predicate devices as described herein. ## Other Information Johnson & Johnson Medical will update and include in this summary any other information deemed reasonably necessary by the FDA {4} DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20856 AUG 18 1997 Ms. Annette M. Hillring Johnson & Johnson Medical Inc. 4110 George Road Tampa, Florida 33634 Re: K970182 DINAMAP* Compact Monitor Regulatory Class: II (two) Product Code: 74 MHX Dated: May 19, 1997 Received: May 20, 1997 Dear Ms. Hillring: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {5} Page 2 - Ms. Annette M. Hillring This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for *in vitro* diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, ![img-0.jpeg](img-0.jpeg) Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {6} # Indications for Use 510(k) Number: K970182 Device Name: DINAMAP* Compact Monitor Indications for Use: The DINAMAP Compact Monitor is intended to monitor a single adult, pediatric or neonatal patient’s vital signs at the bedside. Vital signs parameters include noninvasive blood pressure (systolic, diastolic and mean arterial pressure), pulse rate, temperature and/or oxygen saturation (pulse oximetry). The portable device is designed for use in numerous clinical settings, primarily in various hospital departments such as emergency, radiology, recovery, medical/surgical, labor & delivery, endoscopy, cardiac step-down, etc. and can also be used during many specialized procedures in satellite areas, or in ambulatory surgery centers, physicians’ offices or alternate care settings. (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED.) Concurrence of CDRH, Office of Device Evaluation (ODE) Division Sign-Off) Division of Cardiovascular, Respiratory, and Neurological Devices Prescription Use ☑ (Per 21 CFR 801.109) 510(k) Number K970182 OR Over-The-Counter Use (Optional Format 1-2-96) *Trademark --- **Source:** [https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/MHX/K970182](https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/MHX/K970182) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com